Top Markets
#1 Ontology Gas Ontology Gas +19.23%
#2 Status Status +13.13%
#3 Gas Gas +7.44%
#4 sBTC sBTC +5.95%
#5 Tornado Cash Tornado Cash +5.60%
#6 BCGame Coin BCGame Coin +5.45%
#7 Fake World Assets Fake World Assets +5.29%
#8 B3 (Base) B3 (Base) +5.22%
#9 aelf aelf +5.17%
#10 Ontology Ontology +4.37%
Coin of the day
Ontology Gas Ontology Gas
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
LAVA Therapeutics N.V. LAVA Therapeutics N.V.

LAVA Therapeutics N.V.

LVTX
Classificação em ações #25847
LAVA Therapeutics N.V. is an immuno-oncology firm, currently in the clinical... LAVA Therapeutics N.V. is an immuno-oncology firm, currently in the clinical development phase, dedicated to pioneering novel therapies for cancer. Utilizing its proprietary Gammabody platform, the company engineers innovative bispecific antibodies. These antibodies are specifically designed to engage and harness the potent and precise capabilities of gamma delta T cells, aiming to stimulate a robust anti-tumor immune response and ultimately enhance outcomes for individuals battling cancer. Key compounds in its clinical pipeline include LAVA-051, currently undergoing Phase 1/2a trials for various hematologic malignancies such as chronic lymphocytic leukemia, multiple myeloma, and acute myeloid leukemia. Another front-runner, LAVA-1207, is also in Phase 1/2a clinical studies, targeting metastatic castration-resistant prostate cancer. Furthermore, LAVA Therapeutics is advancing additional Gammabody candidates: LAVA-1223, an investigational treatment for specific solid tumors that targets the epidermal growth factor receptor (EGFR), and preclinical assets LAVA-1266 and LAVA-1278, intended for a range of blood cancers. The company has also forged a research collaboration and licensing partnership with Janssen Biotech, Inc. This alliance focuses on the potential discovery and development of multi-specific antibody therapies aimed at a particular target across diverse therapeutic applications. Established in 2016, LAVA Therapeutics N.V. operates from its headquarters in Utrecht, the Netherlands.
Preço da ação
$1.74
Última sincronização: 2025-11-28
Valor de mercado
$45.77M
Variação (1 dia)
0.00%
Variação (1 ano)
12.26%
País
NL
Negociar LAVA Therapeutics N.V. (LVTX)

Categoria

Healthcare
Histórico de preços das ações de LAVA Therapeutics N.V. (LVTX)
Preço de fecho mais alto: $1.68 em 2025-11-01

Preço de fecho mais baixo: $13.74 em 2021-03-01
Histórico de preços das ações da LAVA Therapeutics N.V. de 2021 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) -5.21%
2025 33.22%
2024 -17.20%
2023 -67.44%
2022 -17.89%
2021 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $539.14 35.65%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 56.21%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $119.69 -17.56%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $761.87 8.65%
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $130.43 397.46%
US